Fed. Circ. Keeps Teva Out Of Luck Over Crestor Patent
Teva Pharmaceutical Industries Ltd. lost its bid Thursday to overturn a lower court's ruling that AstraZeneca PLC did not infringe a Teva patent through its sales of the billion-dollar cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article